Natural history of HIV infection in the era of combination antiretroviral therapy.
about
TAK-652 inhibits CCR5-mediated human immunodeficiency virus type 1 infection in vitro and has favorable pharmacokinetics in humansLife expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studiesRenal transplantation in a HIV positive patientGranulocyte-macrophage colony-stimulating factor as an immune-based therapy in HIV infection.HPV Carcinomas in Immunocompromised PatientsStructure of the HIV-1 Frameshift Site RNA Bound to a Small Molecule Inhibitor of Viral ReplicationGinseng, the natural effectual antiviral: Protective effects of Korean Red Ginseng against viral infectionCauses of death among women with human immunodeficiency virus infection in the era of combination antiretroviral therapyLife expectancy after HIV diagnosis based on data from the counseling center for behavioral diseases.Use of observational data in evaluating treatments: antiretroviral therapy and HIV.Models of accelerated sarcopenia: critical pieces for solving the puzzle of age-related muscle atrophy.Effect of HAART on incident cancer and noncancer AIDS events among male HIV seroconverters.Clinical risk factors for in-hospital mortality in older adults with HIV infection: findings from a South African hospital administrative dataset.A comparison of ad hoc methods to account for non-cancer AIDS and deaths as competing risks when estimating the effect of HAART on incident cancer AIDS among HIV-infected men.Effects of high CD4 cell counts on death and attrition among HIV patients receiving antiretroviral treatment: an observational cohort studyDiscovery of Novel Small-Molecule Inhibitors of LIM Domain Kinase for Inhibiting HIV-1Expenditures for the care of HIV-infected patients in rural areas in China's antiretroviral therapy programs.A double-blind, adjuvant-controlled trial of human immunodeficiency virus type 1 (HIV-1) immunogen (Remune) monotherapy in asymptomatic, HIV-1-infected thai subjects with CD4-cell counts of >300Impact of short-term combined antiretroviral therapy on brain virus burden in simian immunodeficiency virus-infected and CD8+ lymphocyte-depleted rhesus macaques.Incidence and risk factors for AIDS-related mortality in HIV patients in China: a cross-sectional study.Benefit of antiretroviral therapy on survival of human immunodeficiency virus-infected patients admitted to an intensive care unitPulmonary function abnormalities in HIV-infected patients during the current antiretroviral therapy era.Acute depletion of activated memory B cells involves the PD-1 pathway in rapidly progressing SIV-infected macaques.Nutrition in the era of highly active antiretroviral therapy.The cytology of HIV-induced immunosuppression. Changing pattern of disease in the era of highly active antiretroviral therapy.The economic burden of late entry into medical care for patients with HIV infection.Disparities in the burden of HIV/AIDS in CanadaQuality of life of Nigerians living with human immunodeficiency virus.Selected metabolic and morphologic complications associated with highly active antiretroviral therapy.Treatment of hepatitis C and anemia in human immunodeficiency virus-infected patients.The impact of HAART on the respiratory complications of HIV infection: longitudinal trends in the MACS and WIHS cohorts.Does patient sex affect human immunodeficiency virus levels?Associations between use of crack cocaine and HIV-1 disease progression: research findings and implications for mother-to-infant transmission.Factors associated with cancer incidence and with all-cause mortality after cancer diagnosis among human immunodeficiency virus-infected persons during the combination antiretroviral therapy era.Antiviral treatment normalizes neurophysiological but not movement abnormalities in simian immunodeficiency virus-infected monkeysFactors associated with utilization of HAART amongst hard-to-reach HIV-infected individuals in Atlanta, Georgia.Mortality in children and adolescents vertically infected by HIV receiving care at a referral hospital in Vitoria, Brazil.Mortality trends in the US Perinatal AIDS Collaborative Transmission Study (1986-2004)Profile of darunavir in the management of treatment-experienced HIV patientsMultiscale analysis of the murine intestine for modeling human diseases.
P2860
Q24537285-E37579DF-C1DC-4DBF-BE42-0455CC54A8D9Q24597052-CF4AE016-8300-4FF0-BA14-A42205A9741EQ24632815-DBDB63E6-D61A-4F37-9CE3-328FFC34CA0DQ24814373-4FDE56FF-F894-4E11-AD3A-E76B43120AA8Q26799629-CAB59CD3-2667-47B8-BC73-E1A00DAE7512Q27666265-3303314D-85FA-48A5-B8FA-95944034ED5CQ28078859-227EBD63-BF75-46D3-B682-524FCBB0F166Q28389988-C53A4BE3-F32E-41D3-9BDB-B73EA5754084Q30756408-DC59CE78-7445-4026-B4D8-77C61A02C3DBQ30969932-18C7B90E-AF85-4202-8614-BC28B106AFB9Q33349016-82555B01-6C69-4065-9B2B-46CC1A268A02Q33585427-A4F997DB-EDFE-4ED8-90C7-3FF2E1C8ACB3Q33676756-ABC000FE-4041-4404-95FD-881D50DD1F73Q33721818-501DFEE2-4275-4496-8964-0748F4BAE955Q33784615-CFA3A9F4-68A4-4992-AC1B-DCF2969FC579Q33792536-B497A21F-763F-4834-B5DF-EBD403F1FA71Q33795242-E9C7AC3A-794C-4B58-895C-AAE2591F1E4EQ33998567-598EBA30-2B0A-4777-8576-C99691589D82Q34033558-D2FC2C35-B9A4-4BF2-BA64-F0652F589118Q34062712-C4C5DCA1-B61D-45E6-AB8A-EA8A737D7EA7Q34086264-A43F499F-923A-4C4E-9881-E1F3A1775088Q34172133-09F17681-8317-4C64-A01B-D1B1778CF6C4Q34245386-10886BCD-2D10-4888-8B7C-4EC89F33DF87Q34255660-E36FF98B-9DF9-48BF-8460-177688CC43B8Q34448379-8208F566-65FF-49CF-B93A-2E282B24A0FBQ34497355-FF6097B0-EB63-42A4-85C6-1B37B2E2570FQ34499532-431D2CA0-E757-4AA6-BD8F-08F1D623F39EQ34563986-0CCE5555-562C-499E-9478-CC0384BF0BA5Q34631672-26759E20-03F0-433A-800F-BE0BECC275BFQ34631679-0CD6F5F4-665C-4B69-BEFC-0F07D4CD65E5Q34648354-DDC9F30B-4425-4E55-A30D-1895494AA7FCQ34736412-1B9B93DE-283C-4F3E-9088-A277B9B0CC41Q35000633-87ECA2D7-70D1-4E0B-8C27-BA48E348E128Q35071910-8E84B8D0-9FEB-4A4F-A9FE-D229223FDB54Q35128071-3CCF92CB-E1F4-47A1-BFA4-2E430747C3BEQ35174808-2645A076-244C-4C9E-9580-AB9E4B837862Q35234691-C8B17E57-F1A8-44CA-82AD-2FDCEA073FF9Q35452217-DCEE2CB3-9B41-4B9D-89EC-7F94A564B702Q35557212-39D6541B-D4E6-4C9C-87F3-6FAE41A45DEFQ35651919-854E00BC-5CEB-406F-8360-3BCA7FC0508F
P2860
Natural history of HIV infection in the era of combination antiretroviral therapy.
description
1999 nî lūn-bûn
@nan
1999 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Natural history of HIV infection in the era of combination antiretroviral therapy.
@ast
Natural history of HIV infection in the era of combination antiretroviral therapy.
@en
type
label
Natural history of HIV infection in the era of combination antiretroviral therapy.
@ast
Natural history of HIV infection in the era of combination antiretroviral therapy.
@en
prefLabel
Natural history of HIV infection in the era of combination antiretroviral therapy.
@ast
Natural history of HIV infection in the era of combination antiretroviral therapy.
@en
P1433
P1476
Natural history of HIV infection in the era of combination antiretroviral therapy.
@en
P2093
P304
P356
10.1097/00002030-199910010-00017
P407
P577
1999-10-01T00:00:00Z